Bionano Genomics
(NASDAQ) BNGO
Bionano Genomics Financials at a Glance
Market Cap
$12.76M
Revenue (TTM)
$28.51M
Net Income (TTM)
$26.39M
EPS (TTM)
$-5.48
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
2.05 (High)
Dividend
$0.00
Beta (Volatility)
2.05 (High)
Price
$1.15
Volume
327,292
Open
$1.15
Price
$1.15
Volume
327,292
Open
$1.15
Previous Close
$1.16
Daily Range
$1.09 - $1.18
52-Week Range
$1.06 - $5.50
Dividend
$0.00
Beta (Volatility)
2.05 (High)
Price
$1.15
Volume
327,292
Open
$1.15
Previous Close
$1.16
Daily Range
$1.09 - $1.18
52-Week Range
$1.06 - $5.50
BNGO News
BNGO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bionano Genomics
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
97
CEO
Robert Erik Holmlin, PhD, MBA
Website
www.bionano.comHeadquarters
San Diego, CA 92121, US
BNGO Financials
Key Financial Metrics (TTM)
Gross Margin
22%
Operating Margin
-1%
Net Income Margin
-93%
Return on Equity
-66%
Return on Capital
-66%
Return on Assets
-36%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.76M
Shares Outstanding
11.09M
Volume
327.29K
Short Interest
0.00%
Avg. Volume
357.19K
Financials (TTM)
Gross Profit
$6.26M
Operating Income
$33.34M
EBITDA
$23.61M
Operating Cash Flow
$16.34M
Capital Expenditure
$0.00
Free Cash Flow
$16.34M
Cash & ST Invst.
$13.26M
Total Debt
$6.92M
Bionano Genomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.95M
-2.6%
Gross Profit
$3.68M
-207.8%
Gross Margin
-46.31%
N/A
Market Cap
$12.76M
N/A
Market Cap/Employee
$130.16K
N/A
Employees
98
N/A
Net Income
$7.93M
+60.6%
EBITDA
$12.68M
+28.2%
Quarterly Fundamentals
Net Cash
$6.34M
+135.6%
Accounts Receivable
$5.20M
+8.9%
Inventory
$5.45M
-51.0%
Long Term Debt
$5.97M
+62.0%
Short Term Debt
$946.00K
-96.0%
Return on Assets
-35.87%
N/A
Return on Invested Capital
-65.83%
N/A
Free Cash Flow
$4.17M
+35.8%
Operating Cash Flow
$4.17M
+35.8%